Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 3/20 | 0.72 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.69 |
| ▸ | HDAC2 | Q92769 | 6/20 | 0.69 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.64 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.60 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.60 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.60 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.60 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.60 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.60 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.60 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.60 |
| ▸ | ALB | P02768 | 1/20 | 0.58 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8864468 | 1.00 | PPARA (0.72) | PPARAHDAC1HDAC2KCNA3FFAR1 | |
| SCHEMBL1139655 | 1.00 | PPARA (0.72) | PPARAHDAC1HDAC2KCNA3FFAR1 | |
| SCHEMBL11790866 | 1.00 | PPARA (0.72) | PPARAHDAC1HDAC2KCNA3FFAR1 | |
| SCHEMBL712775 | 1.00 | PPARA (0.72) | PPARAHDAC1HDAC2KCNA3FFAR1 | |
| SCHEMBL6342300 | 1.00 | PPARA (0.72) | PPARAHDAC1HDAC2KCNA3FFAR1 | |
| SCHEMBL25228768 | 1.00 | PPARA (0.72) | PPARAHDAC1HDAC2KCNA3FFAR1 | |
| SCHEMBL11616532 | 1.00 | PPARA (0.72) | PPARAHDAC1HDAC2KCNA3FFAR1 | |
| SCHEMBL503552 | 1.00 | PPARA (0.72) | PPARAHDAC1HDAC2KCNA3FFAR1 | |
| SCHEMBL1008297 | 1.00 | PPARA (0.72) | PPARAHDAC1HDAC2KCNA3FFAR1 | |
| SCHEMBL1162023 | 0.98 | PPARA (0.74) | PPARAHDAC1HDAC2KCNA3FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102573790-B | Implantable device for production of interleukin-1 receptor antagonist | 拜欧米特生物制剂有限责任公司 | 2017-03-22 | — | — | CN | claimed |
| US-20090215154-A1 | Method of preparing micro-and nanometric particles with labile Products | SIRROM PARTNERS, L.P. | 2009-08-27 | — | — | US | claimed |
| US-20090214655-A1 | Method and Device for Obtaining Micro and Nanometric Size Particles | SIRROM PARTNERS, L.P. | 2009-08-27 | — | — | US | claimed |
| EP-1951790-A2 | INITIATORS AND CROSSLINKABLE POLYMERIC MATERIALS | A Enterprises, Inc. (US) | 2008-08-06 | — | — | EP | claimed |
| EP-1880762-A2 | METHOD OF PREPARING MICRO- AND NANOMETRIC PARTICLES WITH LABILE PRODUCTS | Universidad de Sevilla (ES) | 2008-01-23 | — | — | EP | claimed |
| EP-1842584-A1 | METHOD AND DEVICE FOR OBTAINING MICRO AND NANOMETRIC SIZE PARTICLES | Universidad de Sevilla (ES) | 2007-10-10 | — | — | EP | claimed |
| WO-2007081396-A9 | INITIATORS AND CROSSLINKABLE POLYMERIC MATERIALS | ENTPR INC A (US) | 2007-09-07 | — | — | WO | claimed |
| WO-2007081396-A2 | INITIATORS AND CROSSLINKABLE POLYMERIC MATERIALS | A ENTERPRISES, INC. (US) | 2007-07-19 | — | — | WO | claimed |
| EP-1118629-B1 | Polyhydroxyalkanoates and method of producing them by utilizing microorganisms | CANON KK (JP) | 2007-04-25 | — | — | EP | claimed |
| US-20060052471-A1 | Initiators and crosslinkable polymeric materials | A ENTERPRISES, INC. | 2006-03-09 | — | — | US | claimed |
| US-20040067576-A1 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2004-04-08 | — | — | US | claimed |
| US-20030208029-A1 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2003-11-06 | — | — | US | claimed |
| US-20030180899-A1 | Process for producing polyhydroxyalkanoates by utilizing microorganisms | HONMA TSUTOMU (JP) | 2003-09-25 | — | — | US | claimed |
| US-6613358-B2 | Contacting an organic solvent with co-dissolved a biocompatible polymer and a hydrophobic ion pair complex of an amphiphilic material and pharmaceutical with a compressed antisolvent fluid | ENDO PHARMACEUTICALS, INC. | 2003-09-02 | — | — | US | claimed |
| US-20020022253-A1 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2002-02-21 | — | — | US | claimed |
| US-20010029039-A1 | Polyhydroxyalkanoates and method of producing them by utilizing mircroorganisms | CANON KABUSHIKI KAISHA (JP) | 2001-10-11 | — | — | US | claimed |
| EP-1118629-A2 | Polyhydroxyalkanoates and method of producing them by utilizing microorganisms | CANON KABUSHIKI KAISHA (JP) | 2001-07-25 | — | — | EP | claimed |
| EP-1113033-A2 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2001-07-04 | — | — | EP | claimed |
| US-12605423-B2 | Peptide inhibitors targeting methyltransfer mechanism of SARS-CoV-2 | UNITED ARAB EMIRATES UNIVERSITY (AE) | 2026-04-21 | — | — | US | disclosed |
| EP-1113033-A2 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2001-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605423-B2 | Peptide inhibitors targeting methyltransfer mechanism of SARS-CoV-2 | METTL16, SARS1, RNMT | PPARA 4087/4885HDAC1 4182/4885HDAC2 3338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.